In 1990, the China Rehabilitation Center conducted preliminary research on bFGF and passed expert acceptance. So far, genetically engineered bFGF was born in China. In the same year, Zhuhai Dongda Biotech spent huge sums of money to purchase the bFGF project, which was still in the basic research stage and was widely concerned by the biomedical community. Since then, the bFGF project has received strong support from the National Science and Technology Commission and has been included in the national "Eighth Five-Year Plan" key scientific and technological research plan.
In 1996, after the hard work of countless scientists, bFGF finally achieved a breakthrough and was officially approved by the then National Ministry of Health as a new drug for repairing skin damage, and was launched for the first time in the world. BFGF was also awarded the Major Achievement Award for the "Eighth Five-Year Plan" Key Scientific and Technological Research Projects, received a Class I New Drug Certificate, and was included in the National "Torch" Plan Project.
In the same year, the NTF project was included in the national "Ninth Five-Year Plan" key scientific and technological projects by the State Science and Technology Commission. NTF also showed its attractive potential in damage repair.
In 1997, Mr. Chua Keng Hiang, a famous Singaporean Chinese investment banker, with his rich business experience, keenly discovered the commercial value of bFGF and other cytokines in medical cosmetology, and invested in the establishment of Beimei International. In the same year, the "Beimei" brand products, whose main products are BFGF solution and BFGF freeze-dried powder, achieved unprecedented success in the beauty industry with its excellent product quality and strong medical and biological background, creating a precedent for bio-beauty in China. , set off a cross-century biological beauty craze across the country. From then on, bFGF and other cytokines began to benefit millions of people who love beauty, and soon became popular, successfully establishing the first repair brand "Beimei".
In 2003, the green technology brand "Plant Integrated Factor" was born with BFGF and NTF as the core ingredients, which were awarded the National Eighth Five-Year Plan and Ninth Five-Year Key Scientific and Technological Research Achievements.
In 2004, Beimei International introduced the results of the American Aoqi Biomolecule Research Center: Biodynes (the world's top bioactive ingredient technology platform), and jointly researched with the Japanese Ford Company to create a new generation of zymbiozomeTM (Lotus) is an OD zero-defect brand with the main ingredient.
In 2006, Beimei International was established ten years ago. Mr. Zhou Shoushan, a Chinese biotechnology expert, combines the latest plant factor patented technology, NTF patented technology and genetically recombinant high-energy complex factors (h-bFGF, h-EGF, h-aFGF, h-PDGF, h-TGF-β, h-KGF , h-VEGF, MIF) and other proprietary technologies are injected into Beimei International, and the company invests and comprehensively manages Beimei with its rich market and management experience. Beimei will once again use its strong technology, capital, market strength and medical background to once again establish Beimei's position as the number one brand in repair.
Organizational chart